Some very good analysis and thoughts here. Enjoyed reading them. On top of this for the first time we will get some insight on:
* Weekly dosing and how it compares to twice weekly
* Canine observations, yes yes preliminary I know
* P3 Look through; its been a while since we last received clinical data.
As I have also said, its 6 monthly that we will also (hopefully [!]) enjoy reading ...its only 4 months away now.
ps: It was good to get MPS update, glad they are successfully working through the stratum in terms of age.
Ann: Successful MPSVI Safety Review and PARA OA 008 Update, page-44
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 99346 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 131244 | 5 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |